Severe acute respiratory syndrome: clinical outcome and prognostic correlates
- PMID: 14519241
- PMCID: PMC3016795
- DOI: 10.3201/eid0909.030362
Severe acute respiratory syndrome: clinical outcome and prognostic correlates
Abstract
Severe acute respiratory syndrome (SARS) poses a major threat to the health of people worldwide. We performed a retrospective case series analysis to assess clinical outcome and identify pretreatment prognostic correlates of SARS, managed under a standardized treatment protocol. We studied 127 male and 196 female patients with a mean age of 41+14 (range 18-83). All patients, except two, received ribavirin and steroid combination therapy. In 115 (36%) patients, the course of disease was limited. Pneumonitis progressed rapidly in the remaining patients. Sixty-seven (21%) patients required intensive care, and 42 (13%) required ventilator support. Advanced age, high admission neutrophil count, and high initial lactate dehydrogenase level were independent correlates of an adverse clinical outcome. SARS-associated coronavirus caused severe illnesses in most patients, despite early treatment with ribavirin and steroid. This study has identified three independent pretreatment prognostic correlates.
Figures
Similar articles
-
Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.Circulation. 2003 Oct 14;108(15):1798-803. doi: 10.1161/01.CIR.0000094737.21775.32. Epub 2003 Sep 22. Circulation. 2003. PMID: 14504188
-
Clinical trials and novel pathogens: lessons learned from SARS.Emerg Infect Dis. 2004 Mar;10(3):389-94. doi: 10.3201/eid1003.030702. Emerg Infect Dis. 2004. PMID: 15109402 Free PMC article.
-
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.Am J Respir Crit Care Med. 2003 Dec 15;168(12):1449-56. doi: 10.1164/rccm.200306-766OC. Epub 2003 Aug 28. Am J Respir Crit Care Med. 2003. PMID: 12947028
-
[Severe acute respiratory syndrome: the first transmissible disease of the 21st century].Recenti Prog Med. 2003 Jul-Aug;94(7-8):295-303. Recenti Prog Med. 2003. PMID: 12868234 Review. Italian.
-
Severe acute respiratory syndrome.Int J Tuberc Lung Dis. 2003 Dec;7(12):1117-30. Int J Tuberc Lung Dis. 2003. PMID: 14677886 Review.
Cited by
-
Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.J Virol. 2007 Feb;81(4):1848-57. doi: 10.1128/JVI.01967-06. Epub 2006 Dec 6. J Virol. 2007. PMID: 17151094 Free PMC article.
-
Long-term sequelae of SARS in children.Paediatr Respir Rev. 2004 Dec;5(4):296-9. doi: 10.1016/j.prrv.2004.07.012. Paediatr Respir Rev. 2004. PMID: 15531253 Free PMC article.
-
Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.Biochem Biophys Res Commun. 2008 Jun 20;371(1):110-3. doi: 10.1016/j.bbrc.2008.04.006. Epub 2008 Apr 10. Biochem Biophys Res Commun. 2008. PMID: 18406349 Free PMC article.
-
Mortality Factor Survey of Severe Acute Respiratory Syndrome in Taiwan.Int J Gerontol. 2009 Mar;3(1):31-38. doi: 10.1016/S1873-9598(09)70018-3. Epub 2009 May 13. Int J Gerontol. 2009. PMID: 32288876 Free PMC article.
-
Delayed lung function testing after COVID-19 to detect persistent lung function abnormalities - The DELTA - COVID-19 lung function study.J Family Med Prim Care. 2022 Nov;11(11):7351-7356. doi: 10.4103/jfmpc.jfmpc_703_22. Epub 2022 Dec 16. J Family Med Prim Care. 2022. PMID: 36993117 Free PMC article.
References
-
- Centers for Disease Control and Prevention. SARS coronavirus sequencing. [Accessed May 26, 2003] Available from: URL: http://www.cdc.gov/ncidod/sars/sequence.htm
-
- WHO. Interim guidelines for national SARS preparedness. [Accessed May 26, 2003] Available from: URL: http://www.wpro.who.int/sars/interim_guidelines/interim_guidelines_26May...
-
- Department of Health. HKSAR. Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong. [Accessed June 2, 2003] Available from: URL: http://www.info.gov.hk/info/ap/pdf/amoy_e.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous